Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Eva-Hip, Evaluation of Rehabilitation After Hip-fracture (Eva-Hip)

This study has been completed.
Trondheim Kommune
Norsk kvinners sanitetsforening
Information provided by (Responsible Party):
Norwegian University of Science and Technology Identifier:
First received: June 15, 2011
Last updated: March 10, 2017
Last verified: March 2017
To evaluate the effect on gait and activity of a home based physiotherapy intervention 4-6 months after the fracture. The investigators hypothesis is that exercises performed after the initial rehabilitation, which focuses on specific components of gait control will improve gait and increase level of activity.

Condition Intervention
Hip Fracture
Procedure: physiotherapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Outcomes Assessor
Primary Purpose: Treatment
Official Title: The Effect on Gait and Activity Level of a Physiotherapy Intervention Aimed at Improving Mediolateral Stability 4 Months After a Hip Fracture

Resource links provided by NLM:

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • change in gait speed [ Time Frame: 4,6 and 12 months postfracture ]

Secondary Outcome Measures:
  • change in activity level [ Time Frame: 4,6 and 12 month postfracture ]

Enrollment: 223
Actual Study Start Date: February 2011
Study Completion Date: June 2016
Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: physiotherapy
Procedure: physiotherapy
exercises, 20 sessions over 10 weeks
No Intervention: conventional treatment
care as usual


Ages Eligible for Study:   70 Years and older   (Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Home dwelling prior to fracture
  • age>70yr
  • able to walk 10m

Exclusion Criteria:

  • expected life expectancies <3 months
  • exercises contraindicated due to medical conditions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01379456

Norwegian University of Science and Technology
Trondheim, Norway, 7006
Sponsors and Collaborators
Norwegian University of Science and Technology
Trondheim Kommune
Norsk kvinners sanitetsforening
Principal Investigator: Olav Sletvold, MD,PHD Department of Neuroscience, Norwegian University of Science and Technology
  More Information

Responsible Party: Norwegian University of Science and Technology Identifier: NCT01379456     History of Changes
Other Study ID Numbers: REK 2010/3265-3
Study First Received: June 15, 2011
Last Updated: March 10, 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries processed this record on May 25, 2017